Searched for
MUMBAI BASED GLENMARK
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDAGlenmark, Alembic Pharmaceuticals, and Sun Pharma are recalling various products in the US due to manufacturing issues, according to the US...
- Glenmark launches biosimilar Adalimumab in IndiaGlenmark did not give any financial detail for the drug, but globally Adalimumab is estimated to be a $16 billion drug in 2016, making it t...
- Kurt Stoeckli to head Glenmark's global research portfolioBased out of Switzerland, Stoeckli will lead Glenmark’s global research portfolio, including biologics (NBEs) and small molecules (NCEs), t...
- Blow to Glenmark: Delhi High Court restrains it from making Zita & Zita-MetHC restrained Glenmark from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met.
- Glenmark Pharmaceuticals discovers new molecule; enters oncology segmentGlenmark announced the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a state...
- Glenmark joins pharma companies setting up US plantsOver the years, leading companies like Ranbaxy, Sun Pharma and Dr Reddy's have either invested in greenfield facilities or acquired existin...
- Glenmark's anti-diabetes drugs shake up Indian anti-diabetes marketThe company has raked in Rs 16 crore in just 8 months since drug was launched.
- Glenmark gets USFDA nod for alcohol abstinence drugGlenmark Pharma said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed Relea...
- No interim relief to Merck against Glenmark’s diabetes genericsDelhi High Court has refused to bar Glenmark from selling the generic versions of anti-diabetic drugs manufactured by Merck Sharp & Dohme.
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- Merck, Glenmark end cholesterol drug rowCos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
- Glenmark in licensing deal with US co for cholesterol drugDrug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic chol...
- Glenmark Generics files for IPOGlenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...
- Teva, Glenmark call an end to patent disputeIsraeli generic major Teva and Mumbai-based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Coreg -...
- Glenmark confirms patent challenge of fluticasone lotionGlenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...
- Glenmark Pharma inks deal with MeyerZall LabsDrug maker Glenmark Pharmaceuticals Ltd has signed a 10-year marketing and distribution rights agreement with South Africa-based MeyerZall ...
- Glenmark gets nod to sell Zofran generic in USGlenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
Load More
